Free Newsletter

The Access Brief

A free daily intelligence briefing on Canadian pharmaceutical policy, health technology assessment decisions, and market access developments — curated and synthesised by AI, reviewed by a pharmacist.

Delivered weekday mornings · Mountain Time · rxlumen.ai

Subscribe — Free

No ads. No sponsorships. Published independently by a pharmacist and market access professional.

Free. No ads. Unsubscribe anytime. Published weekday mornings, MT.

What You Get

🏛️

Regulatory Signals

CADTH, PMPRB, Health Canada — decisions and timelines that move access.

📋

Policy Developments

Federal and provincial policy changes with direct market access implications.

🔬

Science & Evidence

New RCT data, HTA-relevant publications, and pipeline updates.

Archive